- Safety & Recalls
- Regulatory Updates
- Drug Coverage
- COPD
- Cardiovascular
- Obstetrics-Gynecology & Women's Health
- Ophthalmology
- Clinical Pharmacology
- Pediatrics
- Urology
- Pharmacy
- Idiopathic Pulmonary Fibrosis
- Diabetes and Endocrinology
- Allergy, Immunology, and ENT
- Musculoskeletal/Rheumatology
- Respiratory
- Psychiatry and Behavioral Health
- Dermatology
- Oncology
Best Read Product Recall Stories in 2022
Among the most-read product recall stories are those of amoxicillin, metformin, sodium bicarbonate Omnipod 5, and clopidogrel and atenolol.
In First 2022 Recall, Metformin Pulled Back Because of Carcinogenic NDMA
In the first drug recall of 2022, Cranford, New Jersey-based Viona Pharmaceuticals is voluntarily recalling 23 lots of metformin hydrochloride extended-release tablets.
Compounding Pharmacies to Help Alleviate Amoxicillin Shortage
The FDA has released a final guidance document on November 18, stipulating minimum steps pharmacies that compound beta lactam oral antibiotic suspension products must take to mitigate the potential for cross-contamination with other products.
Hospital Demand for Amoxicillin Increases While Shortage Continues
The ongoing amoxicillin shortage is impacting hospitals and pharmacies across the United States. New data from healthcare services firm Vizient is showing a 43% surge in demand for all amoxicillin products in the acute care setting from September to October.
Omnipod 5 Charging Ports are Subject to Overheating
This is second issue related to Omnipod 5. Insulet also had received 50 complaints related to the batteries of Omnipod DASH Personal Diabetes Manager.
Exela Pharma Expands Recall of Sodium Bicarbonate
Exela Pharma is recalling an additional 14 lots of sodium bicarbonate injection because of a broken vial.
Label Mix Up Leads to Recall of Clopidogrel and Atenolol
In one lot, a bottle containing clopidogrel was mislabeled as atenolol. This lot was sold to AmerisourceBergen and McKesson.
